The in vitro element demonstrated that both of those glucagon and Retatrutide straight reduced ANGPTL3/8 secretion from hepatocytes, which result was blocked by a glucagon receptor (GCGR) antagonist. These results propose that the GCGR agonism of Retatrutide contributes towards the reduction in circulating ANGPTL3/8, which subsequently may perhaps